Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mBio
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article | Host-Microbe Biology

Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations

Yuta Hikichi, Rachel Van Duyne, Phuong Pham, Jennifer L. Groebner, Ann Wiegand, John W. Mellors, Mary F. Kearney, Eric O. Freed
Stephen P. Goff, Editor
Yuta Hikichi
aVirus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel Van Duyne
aVirus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phuong Pham
aVirus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer L. Groebner
bTranslational Research Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Wiegand
bTranslational Research Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John W. Mellors
cDepartment of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary F. Kearney
bTranslational Research Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric O. Freed
aVirus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen P. Goff
Columbia University/HHMI
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mBio.03134-20
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplemental Material
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    The location of previously reported Env mutations that overcome blocks to virus replication (48). (A) Schematic of the HIV-1 Env-coding region with the position of mutations indicated using NL4-3 (and HXB2, in parentheses) numbering. Labeled domains are defined as follows: C1 to C5, constant regions 1 to 5; V1 to V5, variable regions 1 to 5; FP, fusion peptide; HR1/HR2, heptad repeat 1/2; DSL, disulfide loop; MPER, membrane proximal external region; TM, transmembrane; CT, cytoplasmic tail. (B) A Env structure of subtype B JR-FL SOSIP.664 (PDB accession number 5FYK [137]) with the position of the Env mutations highlighted. Most of gp120 is shown in white, with gp120 V1/V2 and V3 loops colored in light yellow and light green, respectively. gp41 is colored in tan. Y61, P81, A539, and A556 are highlighted in green, yellow, red, and blue, respectively. Structural model was generated using UCSF Chimera software (138).

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Replication kinetics of Env-A539V in the presence of INSTIs, NRTI, NNRTI, PI, ALLINI, and Ent-Is. The SupT1 T-cell line was transfected with WT or Env-A539V proviral clones in the absence or in the presence of indicated concentrations of ARVs. (A and B) INSTIs; (C and D) NNRTI and NRTI; (E) PI; (F) ALLINI; (G and H) Ent-Is. Virus replication kinetics were monitored by measuring RT activity at the indicated time points. Data are representative of at least two independent experiments. (I) The SupT1 T-cell line was transfected with WT or Env-A539V proviral clones in the absence or in the presence of serial dilutions (0.01 to 3,000 nM) of ARVs. IC50 values were calculated based on RT levels at the peak of virus replication. Fold changes in IC50 were calculated compared to that for the WT. Data from at least two independent experiments are shown as means ± standard errors (SEs). ***, P < 0.001; **, P < 0.01; *, P < 0.05 by unpaired t test. The EFV and NFV data are shown on a separate bar graph to avoid compression of the y axis.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Cell-free infectivity of Env-A539V in the presence or absence of ARVs. (A) RT-normalized virus stocks produced from HeLa cells were used to infect TZM-bl cells. Luciferase activity was measured at 48 h postinfection. Infectivity of WT NL4-3 is normalized to 1.0. (B to I) TZM-bl cells were exposed to 100 TCID50 of WT or Env-A539V virus in the presence of various concentrations (from 0.003 to 3,000 nM) of ARVs and incubated for 48 h. For NFV and BI-224436, 293T cells were transfected with the indicated proviral clones in the presence of the inhibitors. At 48 h posttransfection, the supernatants were used to infect TZM-bl cells. Data from at least three independent experiments are shown as means ± SEs.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Effect of Env-A539V and RT-Y188L mutations on susceptibility to EFV. (A) The SupT1 T-cell line was transfected with the indicated proviral clones in the absence or presence of 1,000 nM EFV. Virus replication kinetics were monitored by measuring RT activity at the indicated time points. Data are representative of three independent experiments. (B) SupT1 T cells were transfected with the indicated proviral clones in the absence or presence of serial dilutions of EFV (0.03 to 1,000 nM). The dose-dependent inhibition curve was determined based on RT values at the peak of multicycle spreading virus replication. (C) TZM-bl cells were exposed to 100 TCID50 of the indicated viruses in the absence or presence of serial dilutions of EFV (0.1 to 10,000 nM). Luciferase activity was measured at 48 h postinfection. (D) IC50 values for EFV in multicycle spreading and cell-free infection based on the data in panels B and C. Data from at least three independent experiments are shown as means ± SEs. Statistical analysis by unpaired t test.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    Effect of Env mutations on sCD4-induced and time-dependent gp120 shedding. (A and B) Concentrated viruses were incubated with sCD4 at the indicated concentrations at 37°C for 0 or 2 h. Incubated viruses were subsequently purified through a 20% sucrose cushion, and viral proteins were detected by Western blotting. (A) A representative gel for the sCD4-induced gp120 shedding assay is shown. (B) The ratio of gp120 to p24 was quantified and plotted. Data from at least two independent experiments are shown as means ± SEs. (C) TZM-bl cells were exposed to 100 TCID50 of the indicated viruses incubated with sCD4 prior to infection for 0 or 2 h. Luciferase activity was measured at 48 h postinfection. Data from three independent experiments are shown as means ± SEs. ***, P < 0.001; **, P < 0.01; *, P < 0.05 by unpaired t test, with asterisks for 0 h or 2 h incubation time points indicated in black or gray, respectively. (D and E) Concentrated viruses were incubated at 37°C for the indicated times. Incubated viruses were subsequently purified through a 20% sucrose cushion, and viral proteins were detected by Western blotting. (D) A representative gel for the time-dependent gp120 shedding assay is shown. (E) The ratio of gp120 to p24 was quantified and plotted. Data from at least three independent experiments are shown as means ± SEs. ***, P < 0.001; **, P < 0.01; *, P < 0.05 by unpaired t test.

  • FIG 6
    • Open in new tab
    • Download powerpoint
    FIG 6

    Sensitivity or binding of Env-A539V to NAbs recognizing different Env conformations, anti-CD4 Ab, and coreceptor antagonist. TZM-bl cells were exposed to 100 TCID50 of WT NL4-3 or Env-A539V viruses in the presence of various concentrations of NAbs (A to J), anti-CD4 Ab (K), and CXCR4 antagonist (L); luciferase activity was measured at 48 h postinfection. Data from three independent experiments are shown as means ± SEs. 293T cells transfected with the green fluorescent protein (GFP)-encoding reporter clone pBR43IeG expressing WT NL4-3 Env or the Env-A539V mutant were preincubated with 17b (M), 10E8 (N), PG16 (O), or PGT145 (P) at 4°C for 1 h. KFS is an Env-defective mutant. The cells were washed, and APC-conjugated anti-human IgG was used to detect bound Ab. APC signals were normalized by GFP signal to calculate the Ab binding efficiency. Data are shown as means ± SEs from three independent experiments. ***, P < 0.001; **, P < 0.01; *, P < 0.05 by unpaired t test or one-way ANOVA and Tukey’s multiple-comparison test.

  • FIG 7
    • Open in new tab
    • Download powerpoint
    FIG 7

    Selection for DTG resistance with the CCR5-tropic NL(AD8) strain. (A) The SupT1huR5 T-cell line was transfected with pNL(AD8) in the absence or presence of 6.0 nM DTG. At the time point indicated by the arrow, DNA was extracted from the DTG-treated culture and the IN- and Env-coding regions were sequenced, leading to the identification of the Env-N654K mutation. (B) An Env structure of subtype B JR-FL SOSIP.664 (PDB accession number 5FYK [137]), highlighting the location of Env mutations selected in the context of NL4-3 (48) and the Env-N654K mutation selected in NL(AD8). Env amino acid positions are indicated using the NL4-3 numbering. Most of gp120 is shown in white, with gp120 V1/V2 and V3 loops colored in light yellow and light green, respectively. Env-Y61, P81, and A556 are highlighted in cyan; Env-A539 and N654 are highlighted in red and purple, respectively. The structural model was generated using the UCSF Chimera software. (C) The SupT1huR5 T-cell line was transfected with WT or mutant pNL(AD8) in the absence or presence of 300 or 0.3 nM DTG. Replication kinetics were monitored by measuring RT activity at the indicated time points. Data are representative of at least three independent experiments. (D) The SupT1huR5 T-cell line was transfected with WT or mutant pNL(AD8) in the absence or presence of a serial dilution of DTG (1,000 nM to 0.03 nM). DTG IC50 values were calculated based on RT values at the peak of virus replication. Fold changes in IC50 relative to that for WT are indicated. Data from at least three independent experiments are shown as means ± SEs. **, P < 0.01; *, P < 0.05 by unpaired t test. (E) RT-normalized virus stocks produced from HeLa cells were used to infect TZM-bl cells. Luciferase activity was measured at 48 h postinfection. ***, P < 0.001 by unpaired t test. (F) TZM-bl cells were exposed to 100 TCID50 of the indicated viruses in the presence of various concentrations of DTG, and luciferase activity was measured at 48 h postinfection. Data are normalized to WT and are shown as means ± SEs from at least three independent experiments.

  • FIG 8
    • Open in new tab
    • Download powerpoint
    FIG 8

    Selection for DTG resistance with the subtype C CCR5-tropic isolate K3016. (A) The SupT1huR5 T-cell line was transfected with the K3016 molecular clone in the presence of 3.0 nM DTG, 2.0 nM RPV, or 100 nM FTC. DNA was extracted from the ARV-treated cultures at the peak of replication, and Env-coding regions were sequenced, leading to the identification of the Env-T541I and Env-E621V mutations. Amino acid numbers are based on HXB2 numbering. (B) gp41 HR1 sequences around the K3016 Env-T541I mutation are shown aligned with the NL4-3 sequence. (C to J) The SupT1huR5 T-cell line was transfected with WT K3016 or the indicated Env variants in the absence of DTG, EFV, NFV, and T-20. The supernatants were collected at the indicated time points and were assayed for replication kinetics by measuring RT activity. Data are representative of at three independent experiments. (K) The SupT1huR5 T-cell line was transfected with WT K3016 or the indicated Env variants in the absence or presence of a serial dilution of DTG, EFV, or NFV (0.01 to 300 nM) or T-20 (0.1 to 3,000 nM). IC50s were calculated based on RT values at the peak of virus replication. Fold changes in IC50 relative to that of WT were calculated. (L) RT-normalized virus stocks produced from 293T cells were used to infect TZM-bl cells. Luciferase activity was measured at 48 h postinfection. (M) TZM-bl cells were exposed to 100 TCID50 of the indicated viruses in the presence of a range of DTG concentrations, and luciferase activity was measured at 48 h postinfection. Data are shown as means ± SEs from three independent experiments. ***, P < 0.001; **, P < 0.01; *, P < 0.05 by one-way ANOVA and Tukey’s multiple-comparison test.

  • FIG 9
    • Open in new tab
    • Download powerpoint
    FIG 9

    The sensitivity of NL(AD8) Env-N654K to NAbs recognizing different Env conformations, anti-CD4 Ab, and entry inhibitors. TZM-bl cells were infected with 100 TCID50 of the indicated viruses in the presence of various concentrations of NAbs (A to G), sCD4 (H), anti-CD4 Ab SIM.4 (I), and entry inhibitors (J to L). Luciferase activity was measured at 48 h postinfection. Data from at least three independent experiments are shown as means ± SEs. ***, P < 0.001; **, P < 0.01; *, P < 0.05 by unpaired t test. The asterisks for 0 h or 2 h incubation with sCD4 (H) are indicated as black or gray, respectively.

    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    FIG 10

    Frequency of observed mutations in gp120 C1 domain and gp41 ectodomain in patient-derived samples from the SELECT study. (A) PID A1, A3, and A5. (B) PID A4. Positions of mutations are indicated using HXB2 numbering. FP, fusion peptide; FPPR, fusion peptide proximal region; HR1/HR2, heptad repeat 1/2; DSL, disulfide loop. Mutations observed in multiple patients are shaded in yellow. Observed residues are indicated in boldface font. Mutations that changed conserved positions to less conserved residues are indicated with a superscript lowercase “a.” Frequencies were determined for subtype C sequences (n = 5,923) retrieved from the Los Alamos HIV databse. Fischer's exact test was performed to determine statistical significance. ***, P , 0.001; **, P , 0.01; *, P , 0.05; ns, not significant; N.D., not determined.

Tables

  • Figures
  • Supplemental Material
  • TABLE 1

    IC50 values in cell-free infection for WT NL4-3 and the A539V variant

    TABLE 1
    • ↵a NS, not significant; ***, P < 0.001; **, P < 0.01; *, P < 0.05.

    • ↵b ND, not determined.

  • TABLE 2

    IC50 values in cell-free infection for NL(AD8) variants

    TABLE 2
    • ↵a NS, not significant; ***, P < 0.001; **, P < 0.01; *, P < 0.05.

    • ↵b ND, not determined.

  • TABLE 3

    Information on study participants failing a RAL-containing regimen

    TABLE 3
    • ↵a PID, participant identifier.

    • ↵b Samples are derived from the SELECT study (5).

    • ↵c RAL resistance mutations are indicated in boldface font.

Supplemental Material

  • Figures
  • Tables
  • FIG S1

    Cell-cell fusion activity of NL4-3 Env-A539V. HEK293T cells were transfected with the indicated proviral clones. At 24 h posttransfection, serial dilutions of the transfected HEK293T cells were cocultured with TZM-bl cells in the presence of a cocktail of EFV and DTG. Luciferase activity was measured at 24 h postinfection. Data from at least three independent experiments are shown as means ± SEs. ***, P < 0.001 by one-way ANOVA and Tukey’s multiple-comparison test. Download FIG S1, TIF file, 0.09 MB.

    This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

  • FIG S2

    Binding of Env-A539V to CD4-IgG2. HEK293T cells transfected with the GFP-encoding reporter clone pBR43IeG expressing WT NL4-3 Env or the Env-A539V mutant were preincubated with 1.0 µg/ml of CD4-IgG2 at 4°C for 1 h. KFS is an Env-defective NL4-3 mutant included as a negative control. The cells were washed, and APC-conjugated anti-human IgG was used to detect bound CD4-IgG2. APC signals were normalized by GFP signal to calculate the CD4-IgG2 binding efficiency. Data are shown as means ± SEs from four independent experiments. *, P < 0.05 by one-way ANOVA and Tukey’s multiple-comparison test. Download FIG S2, TIF file, 0.09 MB.

    This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

  • FIG S3

    Comparison of the sensitivity of NL4-3 and NL(AD8) to NAbs, DTG, T-20, and sCD4 in cell-free infection. TZM-bl cells were infected with 100 TCID50 of the indicated viruses in the presence of various concentrations of NAbs (A to F), ARVs (H and I), and sCD4 (J). sCD4 incubations were performed for 0 or 2 h. The data are related to Fig. 3 and 8. Data from at least three independent experiments are shown as means ± SEs. Download FIG S3, TIF file, 0.5 MB.

    This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

  • FIG S4

    Analysis of sCD4-induced and time-dependent gp120 shedding of NL(AD8) Env mutants and comparison of NL4-3 versus NL(AD8) gp120 shedding. (A) Concentrated viruses were incubated with the indicated concentrations of sCD4 at 37°C for 2 h. Incubated viruses were subsequently purified through 20% sucrose cushions, and viral proteins were detected by Western blotting. A representative gel is shown. (B) Viruses were incubated at 37°C for the indicated times. Incubated viruses were subsequently purified through 20% sucrose cushions, and viral proteins were detected by Western blotting. A representative gel is shown. Quantification of sCD4-induced (C) and time-dependent (D) gp120 shedding from three independent experiments, calculated as the ratios of virion-associated gp120/p24 and shown as means ± SEs. Comparison of NL4-3 and NL(AD8) sCD4-induced (E) and time-dependent (F) gp120 shedding. The data are related to Fig. 5 andS3. Data from at least three independent experiments are shown as means ± SEs. Statistical analysis by unpaired t test. Download FIG S4, TIF file, 0.7 MB.

    This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

PreviousNext
Back to top
Download PDF
Citation Tools
Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations
Yuta Hikichi, Rachel Van Duyne, Phuong Pham, Jennifer L. Groebner, Ann Wiegand, John W. Mellors, Mary F. Kearney, Eric O. Freed
mBio Jan 2021, 12 (1) e03134-20; DOI: 10.1128/mBio.03134-20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mBio article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations
(Your Name) has forwarded a page to you from mBio
(Your Name) thought you would be interested in this article in mBio.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations
Yuta Hikichi, Rachel Van Duyne, Phuong Pham, Jennifer L. Groebner, Ann Wiegand, John W. Mellors, Mary F. Kearney, Eric O. Freed
mBio Jan 2021, 12 (1) e03134-20; DOI: 10.1128/mBio.03134-20
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antiretroviral drugs
envelope glycoprotein
virus transmission
gp41
human immunodeficiency virus

Related Articles

Cited By...

About

  • About mBio
  • Editor in Chief
  • Board of Editors
  • AAM Fellows
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Article Types
  • Ethics
  • Contact Us

Follow #mBio

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2150-7511